首页> 美国卫生研究院文献>Journal of Clinical Oncology >Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

【2h】

Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

机译：腹膜内化疗与静脉化疗对最佳切除III期卵巢癌女性的成本效益：妇科肿瘤学小组研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo determine the cost effectiveness of intraperitoneal versus intravenous regimens for adjuvant treatment of optimally resected stage III ovarian cancer.

机译：目的确定腹膜内和静脉内方案对最佳切除的III期卵巢癌的辅助治疗的成本效益。

著录项

期刊名称 Journal of Clinical Oncology
作者
Laura J. Havrilesky; Angeles Alvarez Secord; Kathleen M. Darcy; Deborah K. Armstrong; Shalini Kulasingam;
展开▼
作者单位

展开▼
年(卷),期 -1(26),25
年度 -1
页码 4144–4150
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Cost effectiveness of intraperitoneal compared with intravenous chemotherapy for women with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. [J] . Havrilesky LJ, Secord AA, Darcy KM, Journal of Clinical Oncology . 2008,第25期

机译：妇科肿瘤学小组的研究显示，腹腔内与静脉化疗相比具有最佳切除效果的III期卵巢癌女性的成本效益。
2. A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: an analysis of patients enrolled in GOG 172. [J] . Krivak TC, Tian C, Rose GS Gynecologic Oncology: An International Journal . 2009,第1期

机译：妇科肿瘤学小组研究与腹腔化疗相比，经腹膜内治疗的III期最佳减灭性卵巢癌患者血清CA-125水平：对GOG 172入组患者的分析。
3. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. [J] . Ozols RF, Bundy BN, Greer BE, Journal of Clinical Oncology . 2003,第17期

机译：卡铂和紫杉醇与顺铂和紫杉醇在最佳切除的III期卵巢癌患者中进行的III期临床试验：妇科肿瘤小组研究。
4. 45 Cases of Surgical Treatment of Ovarian Cancer and Analysis on Effect of Intraperitoneal Chemotherapy [C] . Bao Lihong, Sa Qila, Sun Ping, International Conference on Applied Science, Engineering and Technology . 2017

机译：卵巢癌手术治疗45例及腹膜内化疗分析
5. Comfort Levels of Gynecology Cancer Patients Receiving Intraperitoneal Chemotherapy: A Pilot Study. [D] . Whyte, Darlene. 2010

机译：接受腹腔化疗的妇科癌症患者的舒适度水平：一项先导研究。
6. A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172 [O] . Thomas C. Krivak, Chunqiao Tian, G. Scott Rose, -1

机译：与静脉内化疗相比III阶段阶段最佳消泡卵巢癌患者血清CA-125水平的妇科肿瘤群研究：患有GOG患者172患者的分析
7. Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study [O] . Havrilesky, Laura J., Alvarez Secord, Angeles, Darcy, Kathleen M., 2008

机译：腹膜内化疗与静脉化疗对最佳切除III期卵巢癌女性的成本效益：妇科肿瘤小组研究

Cost Effectiveness of Intraperitoneal Compared With Intravenous Chemotherapy for Women With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

摘要

著录项

相似文献

相关主题

期刊订阅